Detalhe da pesquisa
1.
Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study.
Br J Cancer
; 129(12): 1940-1948, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914801
2.
Oral Tocofersolan Corrects or Prevents Vitamin E Deficiency in Children With Chronic Cholestasis.
J Pediatr Gastroenterol Nutr
; 63(6): 610-615, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27429423
3.
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial.
J Clin Oncol
; 42(9): 1067-1076, 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37963313
4.
A straightforward method to quantify circulating mRNAs as biomarkers of colorectal cancer.
Sci Rep
; 13(1): 2739, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36792801
5.
Preneoplastic Lesions in Surgical Specimens Do Not Worsen the Prognosis of Patients Who Underwent Surgery for Pancreatic Adenocarcinoma: Post-Hoc Analysis of the PRODIGE 24-CCTG PA 6 Trial.
Cancers (Basel)
; 14(16)2022 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36010938
6.
Individual patient data meta-analysis of adjuvant gemcitabine-based chemotherapy for biliary tract cancer: combined analysis of the BCAT and PRODIGE-12 studies.
Eur J Cancer
; 164: 80-87, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35182925
7.
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial.
JAMA Oncol
; 8(11): 1571-1578, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36048453
8.
Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials?
Cancers (Basel)
; 13(7)2021 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33918346
9.
Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study.
Eur J Cancer
; 150: 108-118, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33895682